192 related articles for article (PubMed ID: 29051534)
1. Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation.
Ferlemann FC; Menon V; Condurat AL; Rößler J; Pruszak J
Sci Rep; 2017 Oct; 7(1):13612. PubMed ID: 29051534
[TBL] [Abstract][Full Text] [Related]
2. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation.
Filograna R; Civiero L; Ferrari V; Codolo G; Greggio E; Bubacco L; Beltramini M; Bisaglia M
PLoS One; 2015; 10(8):e0136769. PubMed ID: 26317353
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
[TBL] [Abstract][Full Text] [Related]
6. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
7. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of N‑Myc inhibits neuroblastoma cell growth via the Wnt/β‑catenin signaling pathway.
Wang Y; Gao S; Wang W; Xia Y; Liang J
Mol Med Rep; 2018 Jul; 18(1):377-384. PubMed ID: 29749516
[TBL] [Abstract][Full Text] [Related]
9. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
10. Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Tsafou KP; Horn H; Lindner S; Schulte JH; Eggert A; Jensen LJ; Francavilla C; Olsen JV
Sci Signal; 2015 Apr; 8(374):ra40. PubMed ID: 25921289
[TBL] [Abstract][Full Text] [Related]
11. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells.
Poluha W; Poluha DK; Ross AH
Oncogene; 1995 Jan; 10(1):185-9. PubMed ID: 7824271
[TBL] [Abstract][Full Text] [Related]
12. N-acetylaspartate (NAA) induces neuronal differentiation of SH-SY5Y neuroblastoma cell line and sensitizes it to chemotherapeutic agents.
Mazzoccoli C; Ruggieri V; Tataranni T; Agriesti F; Laurenzana I; Fratello A; Capitanio N; Piccoli C
Oncotarget; 2016 May; 7(18):26235-46. PubMed ID: 27036033
[TBL] [Abstract][Full Text] [Related]
13. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
Kim CJ; Matsuo T; Lee KH; Thiele CJ
Am J Pathol; 1999 Nov; 155(5):1661-70. PubMed ID: 10550322
[TBL] [Abstract][Full Text] [Related]
15. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a new bioactive molecule for neuroblastoma.
Leitão A; Schramm A; Eggert A
Chem Biol Drug Des; 2013 Aug; 82(2):233-41. PubMed ID: 23601248
[TBL] [Abstract][Full Text] [Related]
17. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
19. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
[TBL] [Abstract][Full Text] [Related]
20. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
